Polyphenols against infectious diseases: Controlled release nano-formulations
Authors:
- 1 April 2021
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 161, 66-79
Abstract
No abstract availableKeywords
Funding Information
- Creighton University
This publication has 121 references indexed in Scilit:
- Synthesis of Gelatin-γ-Polyglutamic Acid-Based Hydrogel for the In Vitro Controlled Release of Epigallocatechin Gallate (EGCG) from Camellia sinensisPolymers, 2013
- The Combination of Catechin and Epicatechin Gallate from Fructus Crataegi Potentiates β-Lactam Antibiotics Against Methicillin-Resistant Staphylococcus aureus (MRSA) in Vitro and in VivoInternational Journal of Molecular Sciences, 2013
- Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug DeliveryJournal of Drug Delivery, 2011
- Insertion of Epicatechin Gallate into the Cytoplasmic Membrane of Methicillin-resistant Staphylococcus aureus Disrupts Penicillin-binding Protein (PBP) 2a-mediated β-Lactam Resistance by Delocalizing PBP2Journal of Biological Chemistry, 2010
- Solubility of Gallic Acid, Catechin, and Protocatechuic Acid in Subcritical Water from (298.75 to 415.85) KJournal of Chemical & Engineering Data, 2010
- Mechanisms of Antimicrobial ResistanceDrugs, 2002
- Pseudomonas aeruginosa Reveals High Intrinsic Resistance to Penem Antibiotics: Penem Resistance Mechanisms and Their InterplayAntimicrobial Agents and Chemotherapy, 2001
- Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanismEuropean Journal of Pharmaceutics and Biopharmaceutics, 1998
- Liposomes in treatment of infectious diseasesInternational Journal of Clinical Pharmacy, 1987
- Diffusion of univalent ions across the lamellae of swollen phospholipidsJournal of Molecular Biology, 1965